Rational Advisors LLC Gilead Sciences, Inc. Transaction History

Rational Advisors LLC

$940 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$71.58 - $87.29 $77,807 - $94,884	-1,087 Reduced 17.17%	5,245 $384,000
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $378,219 - $428,910	-5,162 Reduced 81.52%	1,170 $94,000
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $225,305 - $255,501	3,075 Added 94.41%	6,332 $512,000
Q3 2023 Nov 09, 2023	BUY	$73.94 - $80.67 $94,421 - $103,015	1,277 Added 64.49%	3,257 $244,000
Q2 2023 Aug 08, 2023	BUY	$76.01 - $86.7 $132,257 - $150,858	1,740 Added 725.0%	1,980 $152,000
Q2 2022 Aug 09, 2022	BUY	$57.72 - $65.01 $346 - $390	6 Added 2.56%	240 $15,000
Q1 2022 May 10, 2022	BUY	$57.92 - $72.58 $13,553 - $16,983	234 New	234 $14,000
Q4 2020 Feb 05, 2021	SELL	$56.65 - $64.55 $77,383 - $88,175	-1,366 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $71,352 - $89,713	1,149 Added 529.49%	1,366 $87,000
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $403,874 - $468,972	-5,583 Reduced 96.26%	217 $17,000
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $262,983 - $336,843	4,199 Added 262.27%	5,800 $434,000
Q4 2019 Feb 06, 2020	BUY	$61.62 - $67.78 $3,081 - $3,389	50 Added 3.22%	1,601 $104,000
Q3 2019 Nov 06, 2019	SELL	$62.51 - $69.0 $272,106 - $300,357	-4,353 Reduced 73.73%	1,551 $98,000
Q2 2019 Aug 08, 2019	BUY	$61.87 - $69.38 $268,515 - $301,109	4,340 Added 277.49%	5,904 $399,000
Q1 2019 May 08, 2019	BUY	$62.53 - $70.05 $85,541 - $95,828	1,368 Added 697.96%	1,564 $102,000
Q4 2018 Feb 07, 2019	SELL	$60.54 - $79.0 $156,253 - $203,899	-2,581 Reduced 92.94%	196 $12,000
Q3 2018 Nov 08, 2018	BUY	$71.28 - $78.92 $197,017 - $218,134	2,764 Added 21261.54%	2,777 $214,000
Q2 2018 Aug 07, 2018	SELL	$64.88 - $75.68 $324 - $378	-5 Reduced 27.78%	13 $1,000
Q1 2018 May 18, 2018	BUY	$72.84 - $88.8 $1,311 - $1,598	18 New	18 $1,000
Q4 2017 Feb 08, 2018	SELL	$71.15 - $83.52 $149,415 - $175,392	-2,100 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $151,431 - $179,487	2,100	2,100 $170,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rational Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rational Advisors LLC with notifications on news.

Account